MegaWatt V2 Miami Vico By 1st Phorm Overview & Drug Interactions

Check For Interactions With MegaWatt V2 Miami Vico

Supplement: MegaWatt V2 Miami Vico by 1st Phorm

MegaWatt V2 Miami Vico Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with MegaWatt V2 Miami Vico by 1st Phorm

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Scoop(s)
Maximum serving Sizes:
1 Scoop(s)
Servings per container 45

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Creatine Monohydrate
2500 mg
Creatine
Beta-Alanine
1500 mg
Beta-Alanine
Agmatine Sulfate
1000 mg
Agmatine
Ener-G Matrix
342 mg
Proprietary Blend (non-nutrient/non-botanical)
Caffeine Anhydrous
0 NP
Caffeine
Dicaffeine Malate
0 NP
Caffeine
Caffeine Citrate
0 NP
Caffeine
Rauwolscine
0 NP
Rauwolscine

Other Ingredients:
Natural and Artificial flavors
Citric Acid
Sucralose
Silicon Dioxide
Malic Acid
Beta-Carotene


Label Statments:


General Statements
- Advanced intermodal Nootropic pre-workout Nothing compares
Formulation
- Extreme energy & endurance Fierce training sessions Powerful strength & mental focus
FDA Statement of Identity
- Dietary Supplement

Brand Information

See all products by this brand

Not Present
Name 1st Phorm International LLC

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.